Pharmaceuticals, Biotechnology and Life Sciences
BOSTON, May 26, 2021 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development…
THE WOODLANDS, Texas, May 26, 2021 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Lonnel Coats, Lexicon’s…
In the Phase 3 LIBERTY 1 and LIBERTY 2 studies, MYFEMBREE demonstrated 72.1% and 71.2% response rates in menstrual blood…
NEW YORK, May 26, 2021 (GLOBE NEWSWIRE) — BeyondSpring Inc. (“BeyondSpring”) (NASDAQ: BYSI), a global biopharmaceutical company focused on the…
Company announcement – No. 32/ 2021 Zealand Pharma to participate in Jefferies Virtual Healthcare Conference Copenhagen, DK and Boston, MA, U.S.…
FREMONT, Calif., May 26, 2021 (GLOBE NEWSWIRE) — Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that an article…
– Company plans to ask for end-of-Phase 2 meeting with FDA by end of 2021 – Basking Ridge, N.J., May…
BALA CYNWYD, Pa., May 25, 2021 (GLOBE NEWSWIRE) — Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused…
BRIDGEWATER, N.J., May 25, 2021 (GLOBE NEWSWIRE) — Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a fully integrated…
AUSTIN, Texas, May 25, 2021 (GLOBE NEWSWIRE) — TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and…